Nomination period for the Broermann Medical Innovation Award started
- Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine
- Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields
Gießen, January 17, 2025. The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is aimed at scientists worldwide who have carried out pioneering work in medicine, biotechnology, or related fields with their research.
The nomination portal (www.broermann-award.org/nomination/) is open until March 1, 2025. At one million euros, the prize is more valuable than the Nobel Prize for Medicine, making it one of the most highly endowed awards for medical research worldwide.
The international Broermann Medical Innovation Award recognizes research results that demonstrate a high level of innovation for clinical application and thus have the potential to improve the lives and health of millions of people worldwide. The prize is aimed at scientists whose research has been pioneering in the fields of medicine, biotechnology, or related sciences.
The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, the founder of the Asklepios Kliniken. The Broermann gemeinnützige GmbH sponsors the award, and the University Hospital Giessen and Marburg (UKGM) manages the organization. “With this award, we want to honor groundbreaking medical discoveries and highlight those whose research brings real improvements in the prevention or treatment of diseases,” says Prof. Werner Seeger, Chairman of the Award Committee. For the Medical Director of the UKGM, Prof. Friedrich Grimminger, the unique prize reflects the clear conviction of the company founder: “Scientific excellence in medicine is always an international team effort, but without the genius of individual researchers, networks are limited in their impact. These key players and drivers of medical innovation should be promoted and recognized worldwide.”
Nomination process and deadlines
Nominations for the Broermann Medical Innovation Award can be submitted until March 1, 2025. The incumbent Hessian Minister President will present the award in December 2025 at the Hessian State Chancellery in Wiesbaden.
Further information on the award, the nomination criteria, and the selection process can be found at www.broermann-award.org.
Visit Asklepios on the Internet, Facebook or YouTube:
www.asklepios.com/konzern/gesundheitsmagazin
Keywords
Contacts
Broermann Medical Innovation Award
Mirjam Malko
Tel.: +49 (0) 641 / 985-42310
E-Mail: contact@broermann-award.org
Asklepios Kliniken
Corporate Communications and Marketing
Tel.: + 49 (0) 40 / 18 18-82 66 36
E-Mail: presse@asklepios.com
24-hour on-call service for the press office: +49 (0) 40 / 1818-82 8888
RHÖN-KLINIKUM AG
Corporate Communications and Marketing
Heike Ochmann
Press Spokeswoman
Tel.: +49 (0) 9771 / 65-12130
E-Mail: heike.ochmann@rhoen-klinikum-ag.com
MEDICLIN AG
Dr. Janina Lossen
Press Spokeswoman
Tel:. +49 (0) 781 / 488-180
E-Mail: presse@mediclin.de
UKGM
Frank Steibli
Head of Communications and Press Spokesman
Tel.: +49 (0) 641 / 985-51020
Mobile: +49 (0) 160 / 7120456
E-Mail: frank.steibli@uk-gm.de
Links
Subscribe to releases from Asklepios Kliniken GmbH & Co. KGaA
Subscribe to all the latest releases from Asklepios Kliniken GmbH & Co. KGaA by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Asklepios Kliniken GmbH & Co. KGaA
Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award18.11.2025 17:00:00 EET | Press release
Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical achievements visible – and honor those who, with courage, vision, and humanity, are shaping the medicine of tomorrow.”
Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 202518.9.2025 14:31:13 EEST | Press release
With prize money of one million euros, it is one of the most highly endowed medical awards in the world Awarded for groundbreaking pioneering work in cancer therapy using CAR-T cells Award Ceremony with Hessian Prime Minister Boris Rhein Giessen, September 18, 2025. The jury of the Broermann Medical Innovation Award (BMIA) is honoring Dr. Carl June (University of Pennsylvania) and Dr. Michel Sadelain (Columbia University) for their groundbreaking research in the field of CAR-T cell therapy. The Broermann Medical Innovation Award is being presented for the first time this year. With prize money of one million euros, it is among the most highly endowed awards for medical research worldwide.
Nominations for the Broermann Medical Innovation Award 2026 now open5.9.2025 10:20:44 EEST | Press release
With a million euros, it is one of the world’s most highly endowed awards for medical research